Back to 
SHELTON CAPITAL MANAGEMENT
SHELTON CAPITAL MANAGEMENT
NTLA
Showing 0 of 17 quarters
Position history for SHELTON CAPITAL MANAGEMENT's holdings in INTELLIA THERAPEUTICS INC
No. Shelton Capital Management exited its NTLA (Intellia Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 66,500 shares worth $3.7M. Shelton Capital Management already held NTLA in its Q4 2018 13F, the earliest on record, and held it in 16 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.